Lir was founded by Killian Hanlon, Hugh O'Brien.

Who are Lir's investors?

Lir's investors include Amino Collective, Fly Ventures.

Lir

2 known investors

Find your way into Lir

310 people in our graph share verified history with the Lir team — schools, employers, funds. One of them is your warm intro.

Logan Hilleunlockedknows Killian Hanlon · together at Harvard Medical School (overlapped)

×7knows the team · via Harvard Medical School

×4knows the team · via Trinity College Dublin

Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Killian Hanlon inCo-founderKillian Hanlon is co-founder and CEO of Lir Therapeutics, a gene therapy company developing AI-driven optimization of viral vectors. His prior research, documented in peer-reviewed publications, focused on molecular and genetic engineering.

Hugh O'BrieninCo-founder

Investors · 2

Amino CollectiveBerlin · $216K – $1.6M

Fly VenturesBerlin · $1.1M – $4.3M

Frequently asked questions

What does Lir do?: Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.
Who founded Lir?: Lir was founded by Killian Hanlon, Hugh O'Brien.
Who are Lir's investors?: Lir's investors include Amino Collective, Fly Ventures.